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Background: BIOGF1K, a compound K-rich fraction prepared from the root of Panax ginseng, is widely
used for cosmetic purposes in Korea. We investigated the functional mechanisms of the anti-
inﬂammatory and antioxidative activities of BIOGF1K by discovering target enzymes through various
molecular studies.
Methods: We explored the inhibitory mechanisms of BIOGF1K using lipopolysaccharide-mediated in-
ﬂammatory responses, reporter gene assays involving overexpression of toll-like receptor adaptor
molecules, and immunoblotting analysis. We used the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay to
measure the antioxidative activity. We cotransfected adaptor molecules, including the myeloid differ-
entiation primary response gene 88 (MyD88) and Toll/interleukin-receptor domain containing adaptor
molecule-inducing interferon-b (TRIF), to measure the activation of nuclear factor (NF)-kB and interferon
regulatory factor 3 (IRF3).
Results: BIOGF1K suppressed lipopolysaccharide-triggered NO release in macrophages as well as DPPH-
induced electron-donating activity. It also blocked lipopolysaccharide-induced mRNA levels of interferon-b
and inducible nitric oxide synthase. Moreover, BIOGF1K diminished the translocation and activation of IRF3
andNF-kB (p50 andp65). This extract inhibited the upregulation ofNF-kB-linked luciferase activity provoked
byphorbal-12-myristate-13 acetate aswell asMyD88, TRIF, and inhibitor of kB (IkBa) kinase (IKKb), and IRF3-
mediated luciferase activity induced by TRIF and TANK-binding kinase 1 (TBK1). Finally, BIOGF1K down-
regulated the NF-kB pathway by blocking IKKb and the IRF3 pathway by inhibiting TBK1, according to
reporter gene assays, immunoblotting analysis, and an AKT/IKKb/TBK1 overexpression strategy.
Conclusion: Overall, our data suggest that the suppression of IKKb and TBK1, which mediate transcrip-
tional regulation of NF-kB and IRF3, respectively, may contribute to the broad-spectrum inhibitory ac-
tivity of BIOGF1K.
Copyright  2016, The Korean Society of Ginseng, Published by Elsevier. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Inﬂammation is deﬁned as the complex biological response of
the immune system against harmful pathogens [1]. To maintain the
immune homeostasis system in the body, both acute and chronic
inﬂammatory responses play an important role in the naturalof Genetic Engineering, Sungkyunk
aterial Research Team, Amorepaciﬁ
. Park), jaecho@skku.edu (J.Y. Cho)
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d/4.0/).defense mechanisms of the body’s innate immune system. Phago-
cytic uptake of infected materials via receptors, likely toll-like re-
ceptors (TLRs), that interact with molecular patterns of pathogen-
derived materials including lipopolysaccharide (LPS) and peptido-
glycan triggers upregulation of macrophage functions that mediate
inﬂammatory responses [2,3]. To activate inﬂammatory cells,wan University, 2066 Seobu-ro, Suwon 16419, Korea.
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serineethreonine kinases, and inhibitor of kB (IkBa) kinase (IKK)-
activating nuclear factor-kB (NF-kB) are required. Subsequent
transcriptional activation of various inﬂammatory genes such as
inducible nitric oxide (NO) synthase (iNOS) occurs [4,5]. Conse-
quently, several inﬂammatory mediators such as NO and proin-
ﬂammatory cytokines such as interleukin (IL)-1, interferon (IFN)-b,
and tumor necrosis factor-a are secreted to further stimulate other
inﬂammatory cells [6]. These responses help protect the body
against pathogenic infections. Nevertheless, prolonged inﬂamma-
tion causes severe diseases, including cancer, arthritis, diabetes,
and atherosclerosis [7e9]. Thus, in recent decades, immunologists
have focused on the development of safe and effective anti-
inﬂammatory and antioxidative therapy to prevent chronic in-
ﬂammatory diseases.
Numerous studies have expanded our perceptive on the TLR-
signaling pathway [10]. After LPS stimulation, TLR4 is activated
and delivers outside signals into the cytoplasm by recruiting two
adaptor molecules, myeloid differentiation primary response
protein-88 (MyD88) and Toll/IL-1 receptor-domain containing
adaptor molecule-inducing interferon-b (TRIF), through an inter-
action between their Toll/interleukin-1 receptor (TIR) domains [11].
MyD88 and TRIF concurrently interact with various signaling pro-
teins, such as IL-1 receptor-associated kinases (IRAK1 and IRAK4),
protein kinase B (AKT), and TANK-binding kinase 1 (TBK1) [12].
When these proteins are activated, complex signaling cascades
composed of Src, phosphoinositide 3-kinase, phosphoinositide-
dependent kinase-1, and AKT trigger the NF-kB activation
pathway linked to IKK, IkBa [13,14], and the interferon regulatory
factor 3 (IRF3) activation pathway [15]. These two major pathways
participate in the release of proinﬂammatory cytokines and in-
ﬂammatory mediators. Free radicals such as reactive oxygen spe-
cies (ROS) are highly reactive molecules that are generated in
micro- or macrolevel inﬂammatory responses [16,17]. Oxidative
stress can damage proteins, DNA, and small molecules other than
lipids. Biologists and clinicians are interested in the capacity of
antioxidants to defend the human body against damage by reactive
free radicals found in immunological diseases such as cancer,
atherosclerosis, and aging [18,19].
The root of Korean ginseng (Panax ginseng Meyer) has been
prescribed as a herbal medicine in Korea, China, and Japan, and its
pharmacologically active compounds display antioxidant, anti-
inﬂammatory, and anticancer effects [20,21]. Recently, our group
has developed an interesting fraction (BIOGF1K) with a higher
amount of compound K, an active metabolite displaying anti-
inﬂammatory, anticancer, and skin-protective activities [22,23]. In
the present study, we benchmark the molecular mechanisms of
anti-inﬂammatory and antioxidative activities of BIOGF1K by
exploring target proteins through molecular studies.
2. Materials and methods
2.1. Materials
LPS (Escherichia coli 0111:B4), ascorbic acid, phorbal-12-
myristate-13 acetate (PMA), and (3-4-5-dimethylthiazol-2-yl)-2-
5-diphenyltetrazolium bromide (MTT) were obtained from Sigma
Chemical Co. (St. Louis, MO, USA). The luciferase construct with the
NF-kB promoter binding site was used as reported earlier [3]. Fetal
bovine serum and RPMI 1640 were purchased from Gibco (Grand
Island, NY, USA). The cell lines (RAW264.7 and HEK293) used in the
present experiments were obtained from ATCC (Rockville, MD,
USA). All other chemicals were obtained from Sigma Chemical Co.
Total or phospho-speciﬁc antibodies were purchased from Cell
Signaling Technology (Beverly, MA, USA). Plasmid constructscontaining AKT, IKKb, and TBK1 were used as reported previously
[24e26].
2.2. Preparation of BioGF1K
BIOGF1K, a compound K-rich fraction, was gifted by Amor-
epaciﬁc R&D unit (Yongin, Korea). Brieﬂy, P. ginseng root (2 kg) was
pulverized into powder using a mechanical grinder. After weighing,
P. ginseng roots were transferred to a ﬂask, treatedwith 70% ethanol
(4 L) for 2 kg of powdered P. ginseng root, reﬂuxed to extract three
times, and deposited for 6 d at 15C. After that the extracts were
suspended in water and subsequently fractionated using diethyl
ether (1 L) and 1-butanol (500 mL). Dried 1-butanol extract (10 g)
was continuously suspended into a citrate buffer solution (pH 4.0,
1 L) and added with pectinase (15 g, Multifect Pectinase FE, origi-
nating from Aspergillus niger) during agitation in a water bath for
48 h at 30C. After the reaction, the incubation mixture was
extracted using the same amount of ethylacetate three times and
concentrated by speed vac. Finally, BIOGF1K (compound K, 3.2 g,
and ginsenoside F1, 1.5 g) was obtained by separation using column
chromatography (chloroform:methanol ¼ 9:1); yield ¼ 87.8%.
2.3. HPLC analysis
For determination of compound K in BIOGF1K, HPLC was per-
formed as described previously [27,28].
2.4. Cell culture
RAW264.7 and HEK293 cells were cultured in RPMI1640 and
DMEM media, respectively, supplemented with 10% heat-
inactivated fetal bovine serum and 1% antibiotics (penicillin and
streptomycin) at 37C under 5% CO2 [29].
2.5. Drug treatment
A stock solution of BIOGF1K dissolved in 100% dimethyl sulf-
oxide at a concentration of 100 mg/mL was further diluted with the
culture medium, as reported previously [30,31].
2.6. Production of NO
RAW264.7 macrophage cells (1  106 cells/ mL) were cultured
for 18 h, pretreated with BIOGF1K (0e200 mg/ mL) for 1 h, and
further incubated with LPS (1 mg/ mL) for 24 h. The inhibitory effect
of BIOGF1K on NO was determined by Griess assay, as described
previously [32].
2.7. Cell viability test
The cytotoxicity of BIOGF1K was determined with a conven-
tional MTT assay, as described previously [33,34].
2.8. Radical scavenging activity
A 2,2-diphenyl-1-picrylhydrazyl (DPPH) decoloration assay was
carried out as reported previously [35]. Quenching of free radicals
by each fraction and the standard compound was determined
spectrophotometrically at 517 nm against the absorbance of the
DPPH radical. A fresh batch of DPPH solution (20 mg/mL) was pre-
pared for the experiment. The electron-donating activity described
the difference in the absorbance between the mixture and the
control solution, expressed as a percentage:
Table 1
PCR primers used in this study
Name Sequence (50e30)
iNOS F CCCTTCCGAAGTTTCTGGCAGCAG
R GGCTGTCAGAGCCTCGTGGCTTTGG
IFN-b F CAAGTGGAGAGCAGTTGAGGACATC
R TGAGGACATCTCCCACGTCAA
GAPDH F CACTCACGGCAAATTCAACGGCA
R GACTCCACGACATACTCAGCAC
GAPDH, Glyceraldehyde 3-phosphate dehydrogenase; IFN-b, interferon beta; iNOS,
inducible nitric oxide synthase; PCR, polymerase chain reaction
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control  the absorbance of the mixture)/the absorbance of the
control]  100.
2.9. Analysis of mRNA by semiquantitative reverse transcriptase-
polymerase chain reaction
To determine cytokine mRNA expression levels, RAW264.7 cells
were pretreated with BIOGF1K (0e200 mg/mL) for 1 h before
stimulation with LPS (1 mg/mL) for 6 h. Total RNAwas isolated with
TRIzol Reagent (Gibco) according to themanufacturer’s instructions
and stored at 70C for further use. Semiquantitative reverse
transcriptase-polymerase chain reactions were performed as
described previously [36]. The primers listed in Table 1 were syn-
thesized by Bioneer (Seoul, Korea).
2.10. Plasmid transfection and luciferase reporter gene activity
For luciferase reporter assays, HEK293 cells (1  106 cells/mL in
24-well plates) were transfectedwith 1 mg of plasmid-containing b-
galactosidase, NF-kB-Luc, or IRF3-Luc in the presence or absence of
inducing molecules (IKKb or TBK1), using the polyethyleneimine
method. The cells were incubated with BIOGF1K for 24 h before
harvest. Luciferase assays were carried out using the Luciferase
Assay System (Promega, Madison, WI, USA), as described previ-
ously [37]. For immunoblotting analysis, HEK293 cells
(1 107 cells/mL) were transfected with AKT for 48 h or with IKKb
and TBK1 for 24 h before harvesting. Lysates of AKT-overexpressing
cells were subjected to immunoblotting analysis to check the
amount of total or phospho forms of IKKa/b and b-actin.
2.11. Preparation of total lysates and nuclear extracts, and
immunoblotting
Total lysates prepared from HEK293 or RAW264.7 cells
(5  106 cells/ mL) were subjected to western blot analysis of
various total or phospho-proteins. Nuclear lysates were extracted in
a three-step procedure described previously [38]. Total or phos-
phorylated protein levels of transcription factors (p65 and p50),
Akt, IkBa, IKKa/b, TBK1, IRF3, Src, HA, and b-actin (as a control) were
visualized as described previously [39].
2.12. Statistical analysis
All data presented in this paper are the mean  standard devi-
ation of an experiment performed with six (Fig. 1) or three (Figs. 2e
4) replicates. For statistical comparisons, these results were
analyzed using analysis of variance/Scheffe’s post hoc test and
KruskaleWallis/ManneWhitney U tests. A p value < 0.05 was
considered statistically signiﬁcant. All statistical tests were carriedout using the computer program SPSS (version 22.0, 2013; IBM
Corp., Armonk, NY, USA).
3. Results
3.1. Effects of BIOGF1K on NO production and radical scavenging
activity
We ﬁrst investigated BIOGF1K-induced suppression of NO pro-
duction in LPS-treated RAW264.7 cells to determine the ability of
this extract to modulate inﬂammatory responses. LPS upregulated
NO levels in RAW264.7 cells (Fig. 1A), while 200 mg/mL BIOGF1K
suppressed up to 67% of this increase (Fig. 1A, left panel). Mean-
while, the standard NO inhibitory compound L-NAME displayed a
strong inhibitory activity (Fig. 1A, right panel), as expected [40]. To
prove the radical-scavenging activity of BIOGF1K, we employed the
DPPH assay (for electron-donating activities). BIOGF1K showed
signiﬁcant electron-donating activities (p < 0.01), which were
comparable with that of the standard compound ascorbic acid
(100mM; Fig. 1B). Cell viability was intact in RAW264.7 and HEK293
cells treated with BIOGF1K (Fig. 1C), implying that the NO inhibi-
tory activity of this extract was not due to any distracted toxicity.
Finally, the level of compound K in BIOGF1K was analyzed using
HPLC. As Fig. 1D shows, a peak with a similar retention time to
standard compound K was observed at 9.5 min in this extract.
3.2. Effect of BIOGF1K on the transcriptional activity of NF-kB
We examined mRNA levels of an NO-producing enzyme (iNOS)
as well as IFN-b in LPS-treated RAW264.7 cells to determine
whether BIOGF1K-mediated inhibition of NO release is modulated
at the transcriptional or translational level. LPS exposure enhanced
the mRNA levels of iNOS and IFN-b, whereas BIOGF1K remarkably
inhibited the enhancement of these genes at 100 mg/mL and 200 mg/
mL, implying that the transcription process is affected by BIOGF1K
(Fig. 2A). As a conﬁrmation, we employed a luciferase reporter gene
assay with an NF-kB-Luc construct in HEK293 cells treated with
PMA or adaptor molecules (MyD88 and TRIF) to measure the
transcriptional activity of NF-kB [41]. MyD88, TRIF, and PMA alone
strongly enhanced the luciferase activity up to 140-, 14,000-, or 76-
fold, respectively, and addition of BIOGF1K clearly suppressed this
activity by 72% at a dose of 200 mg/mL (Figs. 2Be2D), implying that
BIOGF1K is able to block NF-kB transcriptional activity.
3.3. Effect of BIOGF1K on upstream signaling for NF-kB activation
Next, we examined whether the activation and translocation of
NF-kB could be diminished by BIOGF1K using nuclear fractions,
since the nuclear translocation of NF-kB is required for its activation
[42]. As we expected, BIOGF1K suppressed the enhancement in the
nuclear levels of the NF-kB p65 and p50 subunits at 30e60 min
(Fig. 3A). To further investigate the effect of BIOGF1K on upstream
signaling events for NF-kB translocation, we examined the phos-
phorylation patterns of relevant signaling molecules. As we antic-
ipated, LPS treatment upregulated the phosphorylation of IkBa at
5 min, 15 min, and 30 min, whereas the increased patterns were
time-dependently suppressed by BIOGF1K (Fig. 3B). Furthermore,
phosphorylation of IKKa/b, an upstream kinase of IkBa, was
appreciably blocked by BIOGF1K after 5 min of LPS treatment
(Fig. 3C), signifying that these enzymes may be pharmacologically
targeted by this extract. Furthermore, AKT appreciably enhanced
the level of phospho-IKKa/b, and BIOGF1K suppressed such upre-
gulated phosphorylation (Fig. 3D), implicating that IKKa/bmight be
a target of this extract in NF-kB signaling. To authenticate this
molecular target, we performed NF-kB-mediated luciferase assay
Fig. 1. In vitro anti-inﬂammatory and antioxidative effects of BIOGF1K. (A) The NO level in the culture supernatant of RAW264.7 cells treated with LPS (1 mg/mL) in the presence or
absence of BIOGF1K (left panel) or L-NAME (right panel) for 24 h was analyzed with a Griess assay. (B) The antioxidative activity (electron-donating activity) of BIOGF1K and
ascorbic acid was measured by DPPH assay. After adding an ethanolic DPPH solution, the absorbance was monitored at 517 nm and enzyme activity was calculated as described in
the “Materials and methods” section. (C) Cell viability of RAW264.7 and HEK293 cells under BIOGF1K treatment conditions was determined using the MTT assay. (D) The
phytochemical analysis of the level of compound K in BIOGF1K was analyzed by HPLC. *p < 0.05, compared with the control. **p < 0.01, compared with the control. MTT, (3-4-5-
dimethylthiazol-2-yl)-2-5-diphenyltetrazolium bromide; NO, nitric oxide; DPPH, 2,2-diphenyl-1-picrylhydrazyl.
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Fig. 2. Effect of BIOGF1K on the expression of proinﬂammatory genes and their transcriptional activation. (A) The mRNA levels of iNOS and IFN-b were determined by semi-
quantitative RT-PCR. (BeE) The promoter binding activity of the transcription factor NF-kB was analyzed using a reporter gene assay in HEK293 cells transfected with plasmid
constructs NF-kB-Luc (1 mg/mL), IRF3-Luc (1 mg/mL), b-gal (as a transfection control), PMA (100nM), MyD88 (1 mg/mL), or TRIF (1 mg/mL) in the presence or absence of BIOGF1K.
Luciferase activity was measured using a luminometer. *p < 0.05, compared with the control. **p < 0.01, compared with the control. IFN-b, interferon-beta; iNOS, inducible nitric
oxide synthase; IRF3, interferon regulatory factor 3; LPS, lipopolysaccharide; MyD88, myeloid differentiation primary response gene 88; NF-kB, nuclear factor-kB; PMA, phorbal-12-
myristate-13 acetate; RT-PCR, reverse transcriptase-polymerase chain reaction; TRIF, Toll/interleukin-receptor domain containing adaptor molecule-inducing interferon-b; GAPDH,
Glyceraldehyde 3-phosphate dehydrogenase.
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Fig. 3. Effect of BIOGF1K on activation of NF-kB and its upstream signaling. (A) Levels of p65, p50, and lamin A/C in nuclear fractions were determined by nuclear fractionation and
immunoblotting analysis. (B, C) Phospho-protein or total protein levels of IkBa, IKKa/b, AKT, Src, and b-actin in cell lysates were determined by immunoblotting analysis. (D) The
effect of BIOGF1K on the activation of downstream signaling molecules (IKKa/b) induced by overexpression of AKT was analyzed with immunoblotting analysis. (E) Inhibition of
IKKb-induced NF-kB activation by BIOGF1K was analyzed using a reporter gene assay in HEK293 cells transfected with NF-kB-Luc (1 mg/mL) and IKKb in the presence or absence of
BIOGF1K. Luciferase activity was measured using a luminometer. **p < 0.01, compared with the control. IkBa, c inhibitor of kB; IKK, inhibitor of kB kinase; LPS, lipopolysaccharide;
NF-kB, nuclear factor-kB; HA, hemagglutinin.
J Ginseng Res 2017;41:43e5148under IKKb cotransfection. As we expected, BIOGF1K dose-
dependently blocked NF-kB-mediated luciferase activity induced
by IKKb (Fig. 3E) in a dose-dependent manner.3.4. Effect of BIOGF1K on activation of the IRF3 pathway
As Fig. 2E depicts, TRIF alone induced luciferase activity up to
234-fold, and 200 mg/mL of this extract dose-dependently and
signiﬁcantly (p < 0.01) downregulated luciferase activity up to 63%.
BIOGF1K (200 mg/mL) also suppressed phosphorylated IRF3 in both
nuclear fractions and whole lysates at 30 min (Figs. 4A, 4B). BIO-
GF1K also inhibited the phosphorylation of TBK1 (Fig. 4C), which is
a critical event for IRF3 phosphorylation [15], indicating that TBK1
could be targeted in BIOGF1K-mediated inhibition of IRF3 activa-
tion. Moreover, we investigated the effect of BIOGF1K on upstream
signaling events for IRF3 phosphorylation. LPS-induced phosphor-
ylation of IRF3 was blocked by this extract at 5 min (Fig. 4C), while
phosphorylation of TBK1 at 2 min and 3 min was strongly dimin-
ished. Fig. 4D shows that BIOGF1K was able to dose-dependently
(50 mg/mL and 200 mg/mL) inhibit both events triggered by LPS at
5 min. Validation work with overexpressed TBK1 (Fig. 4E) showedupregulation of TBK1 phosphorylation and IRF3-mediated lucif-
erase activity, conﬁrming that TBK1 might be a target of BIOGF1K-
mediated anti-inﬂammatory action.4. Discussion
Here, we benchmarked in vitro anti-inﬂammatory activities of
BIOGF1K with LPS-treated macrophages and investigated its
electron-donating activity induced by DPPH assay, based on its use
as a skin care product and moisturizer in the cosmetic industry.
Additionally, to elucidate the prospect of developing this extract as
a source of potential anti-inﬂammatory and antioxidative rem-
edies, we identiﬁed the molecular and pharmacological mecha-
nisms of this extract.
As shown in Figs. 1 and 2, BIOGF1K inhibited production of the
inﬂammatory mediator NO and the expression of the inﬂammatory
genes iNOS and IFN-b in LPS-stimulated RAW264.7 cells. As iNOS
expression is increased in various skin diseases such as atopic
eczema and psoriasis [43,44], the inhibitory effect of BIOGF1K on
NO release can explain its known efﬁcacy in cosmetic skin care
formulations as well as in curing various skin inﬂammatory
A B
C D
E
Fig. 4. Effect of BIOGF1K on activation of IRF3 and its upstream signaling. (A) Levels of phospho-IRF3, IRF3, and lamin A/C in nuclear fractions were determined by nuclear
fractionation and immunoblotting analysis. (BeD) Phospho-protein or total protein levels of IRF3, TBK1, and b-actin in whole cell lysates were determined by immunoblotting
analysis. (E) Inhibition of TBK1-induced IRF3 activation by BIOGF1K was analyzed using a reporter gene assay in HEK293 cells transfected with IRF3-Luc (1 mg/mL) and TBK1 in the
presence or absence of BIOGF1K. Luciferase activity was measured using a luminometer. **p < 0.01, compared with the control. IRF3, interferon regulatory factor 3; LPS, lipo-
polysaccharide; TBK1, TANK-binding kinase 1.
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BIOGF1K (Fig. 1B), as assessed by a DPPH assay, can also protect the
skin from stress or UV radiation-induced free radical generation
[45]. In fact, strong antioxidants are popularly used in many skin
care formulations and as a functional food source [46,47]. Although
BIOGF1K was prepared to increase the level of compound K from
ginseng roots, as shown in Fig. 1D, these effects on NO production
and antioxidative activity were similar to those reported from
Korean Red Ginseng water extract and ginseng saponin fraction
[20,48]. Therefore, the anti-inﬂammatory and antioxidative com-
ponents of Korean ginseng could also be extracted in BIOGF1K.
To elucidate the molecular mechanisms of BIOGF1K-mediated
anti-inﬂammatory activity, we explored its effect on the activa-
tion of NF-kB, a key transcription factor modulating inﬂammation[49]. Overall, the data imply that the NF-kB pathway might be a
target transcription factor in the BIOGF1K-mediated anti-inﬂam-
matory effect. BIOGF1K blocked nuclear translocation of NF-kB
subunits (p50 and p65; Fig. 3A) and diminished PMA-induced and
MyD88- or TRIF-mediated NF-kB activation (Figs. 2Be2D). BIOGF1K
also suppressed IkBa phosphorylation, which is an essential step for
NF-kB translocation [50] (Fig. 3B). Phosphorylation of IKKa/b was
strongly diminished by this extract at 2e5 min under LPS-
stimulated conditions (Fig. 3C). Overexpression of IKKb increased
NF-kB-mediated luciferase activities up to more than 4,000-fold,
which was dose-dependently diminished by BIOGF1K (Fig. 3E).
Moreover, molecular validation work with AKT and IKKb over-
expression in a reporter gene assay (Fig. 3E) and in immunoblotting
analysis (Fig. 3D) clearly conﬁrmed that IKKb could directly be
Fig. 5. Putative mechanism of BIOGF1K-mediated anti-inﬂammatory responses. IFN-b,
interferon-beta; IkBa. inhibitor of kB; IKK, inhibitor of kB kinase; iNOS, inducible nitric
oxide synthase; IRF3, interferon regulatory factor 3; LPS, lipopolysaccharide; MyD88,
myeloid differentiation primary response gene 88; NF-kB, nuclear factor-kB; NO, nitric
oxide; TBK1, TANK-binding kinase 1; TLR, toll-like receptor; TRIF, Toll/interleukin-
receptor domain containing adaptor molecule-inducing interferon-b.
J Ginseng Res 2017;41:43e5150targeted for suppression of the NF-kB pathway by BIOGF1K. Other
phytomedicinal plants such as Cordyceps pruinosa, Davallia bila-
biata, Euonymus alatus, and Cynanchi atrati, and some ﬂavonoids
such as myricetin also display NF-kB-targeted anti-inﬂammatory
activities through inhibition of IKK [4,51e53]. Considering these
ﬁndings, our data strongly indicate that the anti-inﬂammatory ac-
tion of BIOGF1K ismediated by blockade of NF-kB after inhibition of
IKK. In addition, compound K, as an active component of ginseng-
derived ginsenosides, is able to suppress NF-kB activation in tu-
mor necrosis factor-a-treated human astroglial cells [54] and under
dextran sulfate sodium-induced colitic conditions [55]. Therefore,
the IKKb/NF-kB inhibitory action of BIOGF1K can be derived from
its major component, compound K.
We previously reported that Korean Red Ginseng water extract
and protopanaxadiol saponin fraction are capable of blocking IRF3
activation [20,56]. Since the inhibitory activity of BIOGF1K on the
IKKb/NF-kB pathway is still marginal, it may have additional tar-
gets. BIOGF1K negatively regulated the activation of IRF3 (Figs. 2E,
4), suggesting that the IRF3 pathway might be another target in
BIOGF1K-mediated anti-inﬂammatory action. BIOGF1K diminished
nuclear translocation of phospo-IRF3 (Fig. 4A), dose-dependently
suppressed the TRIF-induced promoter binding activity of IRF3
(Fig. 2E), and suppressed IRF3 phosphorylation in LPS-stimulated
RAW264.7 cells (Fig. 3B). In addition, BIOGF1K diminished TBK1
and IRF3 phosphorylation at 2e5 min under LPS-exposed condi-
tions in a dose-dependent manner (Figs. 4C, 4D) and signiﬁcantly
inhibited TBK1/IRF3-mediated luciferase activity (Fig. 4E). Molec-
ular validation work under TBK1-overexpression conditions also
suggests that TBK1 could be another anti-inﬂammatory target
protein of BIOGF1K (Fig. 4). Interestingly, other herbal plants such
as Dryopteris crassirhizoma also exhibited IRF3-targeted anti-
inﬂammatory activities through the suppression of TBK1 [20,57].
Our data strongly imply that suppression of the TBK1/IRF3 pathway
could, in part, contribute to the immunopharmacological activity of
BIOGF1K.In summary, BIOGF1K possesses strong in vitro antioxidative and
anti-inﬂammatory activities through blockade of both IKK and
TBK1, and suppression of the downstream activation of NF-kB and
IRF3, as described in Fig. 5. Further studies will focus on validating
BIOGF1K as a new anti-inﬂammatory candidate in preclinical
studies.
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